This study aimed to develop, validate, and introduce two patient reported outcome measures (PROMs) for patients with abdominal aortic aneurysm (AAA): the AAA-Symptoms and AAA-Quality of Life (AAA-QoL).
This first in human study evaluated the six month angiographic and one year clinical outcomes of a novel thin strut, sirolimus eluting, resorbable scaffold for symptomatic below the knee peripheral arterial disease (PAD). RESOLV I is an international, prospective, multicentre, single arm study assessing the performance of the MAGNITUDE drug eluting resorbable scaffold (DRS) for the treatment of below the knee lesions in patients with symptomatic PAD.
Type A acute aortic dissection (TAAAD) is associated with a high risk of surgical mortality despite early diagnosis and treatment. The optimal extent of aortic arch repair for primary TAAAD remains unclear. This study aimed to investigate the outcomes of the frozen elephant trunk (FET) procedure compared with non-FET procedures in patients with primary TAAAD.